The Hyperoxaluria Drug market was valued at USD 19.43 Million in 2024 and is expected to reach USD 32.30 Million by 2032, growing at a CAGR of 6.6% (2024-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.